About IDRx
IDRx is a clinical-stage biopharmaceutical company that develops oncology-based precision therapies. It designs precision combination therapies, which are medicines with engineered drug combinations. These therapies aim to stop key tumor escape mechanisms and prolong response to therapy for gastrointestinal stromal tumors.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $120,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $122,000,000 · Series-A
fundraisingfox.com
- Milestone
Company founded
Cambridge, United States
- Milestone
Website domain registered
idrx.com
Investors & Backers
Funding History
Founders & Leadership
Alexis Borisy
Founder
Ben Auspitz
Founder
George Demetri
Founder
Jessica Anderson
Chief Development Operations Officer
Jessica Christo
Chief Development Operations Officer
Nick Lydon
Founder
Robert Forrester
Founder
Shrenik Desai
Vice President, Regulatory Affairs
Vic Kadambi
Chief Product Development Officer
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com